Overview of Dr. Moore
Anne Moore, MD is a New York-based Oncologist with subspecialties in Breast Cancer and Hematologic Oncology. She completed her education at the Columbia University Vagelos College of Physicians and Surgeons and her residency in Internal Medicine at New York Presbyterian Hospital. Dr. Moore has experience with vocal cord cancer and has several publications in esteemed journals, such as Breast Cancer Research and Treatment and Journal of Evidence-Based Complementary & Alternative Medicine. She is recognized for her work, holding honors such as the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, and being named a Super Doctor by SuperDoctors.com and Top MD by Consumers Checkbook.
Office
425 E. 61st St.
8-11th Floor
New York, NY 10065
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1970 - 1973- New York Presbyterian HospitalInternship, Transitional Year, 1969 - 1970
Columbia University Vagelos College of Physicians and SurgeonsClass of 1969
Certifications & Licensure
NY State Medical License 1972 - 2025
CO State Medical License 2014 - 2017
MN State Medical License 2004 - 2017
OR State Medical License 1984 - 2017
NC State Medical License 2012 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 5 citationsBenefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.Genevieve A Fasano, Solange Bayard, Yalei Chen, Leticia Varella, Tessa Cigler
Breast Cancer Research and Treatment. 2022-02-01 - 3 citationsDietary supplement use and documentation in a breast cancer survivorship clinic.Julia Silver, Alyson Goldenberg, Anne Moore
Breast Cancer Research and Treatment. 2021-11-24 - 35 citationsTetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.Ying L. Liu, Cecilie L. Bager, Nicholas Willumsen, Divya Ramchandani, Naomi Kornhauser
NPJ Breast Cancer. 2021-08-23
Press Mentions
Treatments Focus on Preventing, as Well as Curing, Breast CancerJune 27th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
